| Literature DB >> 30759797 |
Marco Gerdol1, Manuela Cervelli2, Paolo Mariottini3, Marco Oliverio4, Sébastien Dutertre5, Maria Vittoria Modica6,7.
Abstract
Proteins of the ShK superfamily are characterized by a small conserved domain (ShKT), first discovered in small venom peptides produced by sea anemones, and acting as specific inhibitors of voltage-dependent and calcium-activated K⁺ channels. The ShK superfamily includes both small toxic peptides and larger multifunctional proteins with various functions. ShK toxins are often important components of animal venoms, where they perform different biological functions including neurotoxic and immunosuppressive effects. Given their high specificity and effectiveness, they are currently regarded as promising pharmacological lead compounds for the treatment of autoimmune diseases. Here, we report on the molecular analysis of ShKT domain containing proteins produced by the Mediterranean vampire snail Cumia reticulata, an ectoparasitic gastropod that feeds on benthic fishes. The high specificity of expression of most ShK transcripts in salivary glands identifies them as relevant components of C. reticulata venom. These ShK proteins display various structural architectures, being produced either as single-domain secretory peptides, or as larger proteins combining the ShKT with M12 or CAP domains. Both ShKT-containing genes and their internal ShKT domains undergo frequent duplication events in C. reticulata, ensuring a high level of variability that is likely to play a role in increasing the range of their potential molecular targets.Entities:
Keywords: Astacin; CRISP; Gastropoda; ShKT; domain duplication; gene duplication; haematophagy; parasitism
Mesh:
Substances:
Year: 2019 PMID: 30759797 PMCID: PMC6409789 DOI: 10.3390/toxins11020106
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1(A) Multiple sequence alignment of the 14 ShKL proteins from Cumia reticulata. The sequence consensus is indicated as a sequence logo below the alignment. (B) Schematic representation of ShKL and multiShKL proteins. Each domain is shown with a box of different colour. ShKT and ShKT-like: ShK toxin and ShK toxin-like domains; note that multiShKL proteins can either contain four canonical ShKT domains (as in the case of multiShKL 1) or a three canonical plus a ShKT-like domain (as in the case of multiShKL 2, 3 and 4). (C) Multiple sequence alignment of ShKT domains from ShKL proteins. The domain consensus is indicated as a sequence logo below the alignment. (D) Expression pattern of ShKL transcripts, based on Modica et al. [24]. Expression levels are given as Log(TPM). SG: salivary gland; MO: mid-oesophageal gland; WB: whole body. (E) Bayesian analysis of C. reticulata ShKL and multiShKL proteins. SG-specific genes are highlighted with a yellow background. Posterior probability support values are shown for each node.
Figure 2(A) Schematic representation of CreCAP-ShK proteins. Each domain is shown as a box of different color. CAP: cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins domain; ShKT: ShK toxin domain; EGF-like: epidermal growth factor-like domain; Cys-rich: other uncharacterized cysteine-rich motifs. (B) Multiple sequence alignment of ShKT domains from CreCAP-ShK proteins. The domain consensus is indicated as a sequence logo below the alignment. (C) Multiple sequence alignment of EGF-like domains from CreCAP-ShK proteins. The domain consensus is indicated as a sequence logo below the alignment. (D) Expression pattern of CreCAP-ShK transcripts, based on Modica et al. [24]. Expression levels are given as Log(TPM). SG: salivary gland; MO: mid-oesophageal gland; WB: whole body. (E) Structure and disulfide connectivity of ShKT (left) and EGF-like (right) domains, as exemplified by crystal structures of the Stichodactyla helianthus ShK toxin (PDB ID: 1ROO) and the human factor VII (PDB ID: 1BF9).
Figure 3Bayesian analysis of CAP-ShK proteins and other related invertebrate proteins. CreCAP-ShK sequences are highlighted with a yellow background. Posterior probability support values are shown for each node, and nodes with low support (<50%) have been collapsed. Sequences are named as follows: the first three letters of the genus and species name, followed by the sequence accession ID.
Figure 4(A) Schematic representation of CreM12-ShK proteins. Each domain is shown as a box of different colour. M12: MEROPS peptidase family M12; ShKT and ShKT-like: ShK toxin and ShK toxin-like domains; Cys-rich: uncharacterized cysteine-rich motifs. (B) Multiple sequence alignment of ShKT domains from CreM12-ShK proteins. The domain consensus is indicated as a sequence logo below the alignment. (C) Multiple sequence alignment of the uncharacterized cysteine-rich motifs located in an N-terminal position compared to the first ShKT domain in CreM12-ShK proteins. The domain consensus is indicated as a sequence logo below the alignment. (D) Expression pattern of CreM12-ShK transcripts, based on Modica et al. [24]. Expression levels are given as Log(TPM). SG: salivary gland; MO: mid-oesophageal gland; WB: whole body. (E) Conservation of the zinc-binding motif in CreM12-ShK proteins and comparison with the consensus sequence from Pfam (PF01400).